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captured in the statistical models, leaving 
a residual effect of genotype apparently 
independent of MC1R. However, this 
viewpoint looks increasingly wide of the 
mark. Various groups have subsequently 
suggested that MC1R influences DNA 
damage and DNA repair in ways that 
are not explicable in terms of pigmen-
tary status (Böhm et al., 2005; Hauser 
et al., 2006). More recently, Greg Barsh, 
on the basis of gene-array experiments 
performed on neonatal mouse skin, 
demonstrated that the pattern of gene 
expression differs in mice depending on 
mc1r status (April and Barsh, 2007), and 
Landi et al. (2006) showed that there is a 
curious and consistent relation between 
MC1R status and the presence of BRAF 
mutations in melanoma. All these studies 
are in keeping with the idea that MC1R 
affects a range of key regulatory path-
ways involved in cell cycle control and 
apoptosis, not only in melanocytes but 
also in the surrounding keratinocytes. To 
this evidence from diverse sources must 
now be added the work of Robinson et 
al. (2010).
Several years ago, Jeff Mogil was 
mapping quantitative trait loci in mice 
associated with responses to pain (Mogil 
et al., 2003). Surprisingly, one locus that 
seemed important turned out to be the 
mc1r. Subsequent work has extended 
these studies into humans, although the 
picture at present remains unclear, with 
some effects seen only in females and 
the effects restricted to certain types of 
pain. As yet, we have little idea of any 
mechanism to account for these puz-
zling results. But again, MC1R seems to 
be doing things we hadn’t imagined only 
a short while ago. Pigment in nature is 
often used either to attract attention (as 
in sexual behavior) or to do the opposite, 
i.e., to act as camouflage. MC1R plays 
a key role in determining the type and 
extent of human pigmentation. Some of 
us have perhaps been slow to see exact-
ly what this MC1R-associated pigment 
was concealing.
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Two-Way Traffic on the Bridge  
from Innate to Adaptive Immunity
Stephen E. Ullrich1
Conventional wisdom suggests that information is usually transmitted from the 
dendritic cell (DC) to the T cell.  In this issue, Schwarz and Schwarz demonstrate 
that UV-induced T regulatory cells (Tregs) can influence the biology of naïve DC. 
They report that IL-10-secreting Tregs prime DC to activate additional Tregs 
when injected into naïve mice.  It may be possible to use DCs that have been 
“educated” by Tregs to induce immune tolerance in vivo.  
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Most introductory immunology courses 
for first-year medical and/or graduate 
students follow a fairly predictable path. 
First we introduce the players, i.e., the 
cells and molecules that constitute the 
immune system. We then introduce the 
processes that differentiate “self” from 
“nonself,” thereby protecting against 
microbial infection. Innate and adap-
tive immune reactions are introduced 
early in the class, and inevitably stu-
dents are told that dendritic cells (DCs) 
are the bridge between the innate and 
adaptive immune responses. We then 
describe how DCs process foreign anti-
gens and present them to T cells. We 
discuss costimulatory molecules and 
the immune synapse formed between 
DCs and T cells, as well as the genera-
tion of helper and effector cells that 
ultimately drive adaptive immunity. For 
the most part, and usually for the sake 
of simplicity, we describe a one-way 
pathway of information from DCs to T 
cells.
For several years, however, immu-
nologists have realized that information 
flowing from T cells to DCs can influ-
ence DC function. For example, 
Shreedhar and colleagues (1999) report-
ed that T-cell function is critical for DC 
maturation and migration in vivo. The 
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number of Langerhans cells in the skin 
of T-cell-deficient mice—severe com-
bined immuno deficient (SCID) and 
Rag2−/−—was significantly depressed 
when compared with that of wild-type 
controls. The few Langerhans cells found 
in the skin of the T-cell-deficient mice 
were smaller and less dendritic than 
those of wild-type controls. Moreover, 
the antigen-presenting-cell function of 
DCs isolated from T-cell-deficient mice 
was significantly depressed. The defects 
in epidermal cell number, antigen pre-
sentation, and DC appearance were 
reversed following reconstitution of 
the SCID or Rag2−/− mice with normal 
T cells. Cytokines released by activated 
T cells (tumor necrosis factor (TNF)-α 
and TNF-related activation-induced 
cytokine (TRANCE)) and CD40–CD40 
ligand binding are known to play cru-
cial roles in DC activation, matura-
tion, and survival (Wong et al., 1997; 
Moodycliffe et al., 2000) in vivo. Data 
from these types of experiments indicate 
that the one-way information pathway 
used to describe DC–T-cell interaction 
is overly simplistic; information can 
flow from the T cell to the DCs, where it 
can modulate DC function (Figure 1).
In this issue, Schwarz and Schwarz 
present data that not only confirm the 
concept that T cells can affect DC func-
tion but greatly expand on that idea by 
demonstrating that, after the interaction 
of antigen-specific T regulatory cells 
with DCs, DC function is switched from 
immunostimulatory to immunosuppres-
sive. T regulatory cells, formerly known 
as T suppressor cells, have an interest-
ing and controversial history. In the late 
1970s and early 1980s, the existence of 
a lineage of T cells that suppresses the 
immune response was well accepted 
by immunologists. Unfortunately, the 
inability to clone these cells and the 
failure to identify unique receptors on 
their surface, along with the inability 
to clone the putative restriction factor 
(e.g., I–J) involved in T-cell suppression, 
led to the demise of the reputation of 
T suppressor cells in the immunology 
community—it became unacceptable 
to mention the words “T suppressor 
cell” in polite company. The idea that a 
lineage of T cells had suppressive activ-
ity became acceptable again in the mid 
to late 1990s, following the observation 
that CD4+CD25+ T cells—cells that 
specifically express the transcription 
factor Foxp3—have suppressive activity 
and that they were important in regulat-
ing autoimmunity, transplant rejection, 
antimicrobial immune reactions, and 
tumor immunity (reviewed by Sakaguchi 
et al., 2007). The return of suppressor 
T cells to the immunologic family was 
facilitated by a change in name (T sup-
pressor cells became T regulatory cells 
(Tregs)). A cursory search of PubMed 
confirms that Treg cell biology is once 
again a hot topic in immunology.
Photoimmunologists, on the other 
hand, never quite abandoned the idea 
of immunosuppression by T cells. This 
consistency was based on the strength 
of the basic biology: transferring T cells 
from UV-irradiated mice into normal, 
immunocompetent, unconditioned 
recipients transferred immunosuppres-
sion and susceptibility to skin cancer 
induction (Elmets et al., 1983; Fisher 
and Kripke, 1982).
In the experiments performed by 
Schwarz and Schwarz (2010, this issue), 
mice were exposed to UV radiation and 
then sensitized with the hapten dinitro-
fluorobenzene (DNFB)—a well-known 
procedure for inducing Tregs. The Tregs 
were isolated from the lymph nodes of 
the irradiated mice and cocultured with 
bone marrow–derived DNFB-coupled 
DCs. The DCs were then isolated and 
injected into naïve mice. Generally, 
injection of hapten-coupled DCs induc-
es a vigorous contact-hypersensitivity 
response in mice. However, coincu-
bating the DCs with Tregs ablated their 
ability to induce contact hypersensi-
tivity, indicating that the DCs had lost 
their sensitizing capability. This effect 
was hapten specific, and the mediator 
Clinical Implications
•  T cells have the capacity to influence the function of dendritic cells (DCs).
•  UV-induced T regulatory cells (Tregs) are able to switch the phenotype 
of DCs from stimulatory to suppressive.
•  Hypothesis: vaccines using DCs that are “educated” first by Tregs can be 
employed to induce antigen-specific suppression of unwanted immune 
responses (i.e., transplant rejection).
Figure 1. transfer of information between Dc and tregs. (a) The conventional view of DC–T cell 
interaction. Antigen (Ag)-pulsed DCs initiate cell activation and proliferation, which eventually results 
in the activation of lineage-specific transcription factors and then results in the differentiation of T cells 
into various helper phenotypes, including T helper (Th)-1, Th2, Th17, T follicular helper (Tfh) cells, and 
T regulatory cells (Tregs). (b) UVB-induced Tregs, via the release of IL-10, can induce DCs to switch their 
phenotype from immunostimulatory to immunoregulatory, in part by upregulating the expression of 
immunosuppressive costimulatory molecules (B7-H3 and B7-H4). Injecting the immunoregulatory DCs 
into a naive recipient promotes the activation and maturation of more Tregs in the normal host.
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was IL-10. Tregs from IL-10-deficient 
mice did affect the sensitizing ability of 
the hapten-coupled DCs. Cell-to-cell 
contact was required—the authors sug-
gest that the Tregs must be activated by 
the DCs to release IL-10. But perhaps 
the most interesting observation is that, 
when the DCs that had been incubated 
with the Tregs were injected into a naïve 
mouse, not only did they fail to induce 
contact hypersensitivity in that mouse 
but there was activation of more Tregs in 
the recipient animal. These findings indi-
cate that Tregs, via the release of IL-10, 
both suppress antigen-presenting cell 
function (a well-known consequence of 
IL-10 on DC function) and change their 
phenotype from immunostimulatory 
to immunoregulatory. Furthermore, 
these regulatory DCs can then induce 
the activation of more Tregs in the 
naïve recipients, thus amplifying their 
immuno suppressive function.
Although we generally associate 
UV-induced immunosuppression with 
a negative consequence (the induction 
of skin cancer), there are many situa-
tions in which clinicians want to turn off 
an unwanted immune response in an 
antigen-specific fashion (e.g., in cases 
of autoimmunity, allergy, and transplant 
rejection). It is conceivable that the abil-
ity of Tregs to influence DC function 
will make it possible to achieve this 
aim. For more than 10 years, immu-
nologists have used DC vaccines to 
treat melanoma, so the technology and 
experience needed to prepare patient-
quality DCs are available (Ueno et al., 
2010); the challenge will be to generate 
the Tregs. Schwarz and Schwarz (2010, 
this issue) isolated Tregs from the lymph 
nodes of UV-irradiated mice, so it is dif-
ficult to see how this can be adapted to 
the clinic. But it should be noted that 
human Tregs have been induced to pro-
liferate and expand in vitro (Strauss et 
al., 2007), so it is conceivable that an in 
vitro culture system using CD4+CD25+ 
Tregs and antigen-pulsed DCs may pro-
vide a way to generate immunomodu-
latory DCs. Although simple injec-
tion of Tregs would probably achieve 
this end, it is natural for DCs to come 
in contact with and activate many 
T cells in vivo; therefore, it is conceiv-
able that injecting properly “educated” 
DCs may be a better way to amplify the 
immunosuppressive loop. Thus, the data 
presented by Schwarz and Schwarz 
confirm the role that T cells play in DC 
function/differentiation. Furthermore, 
they point out that Tregs transmit infor-
mation to DCs that profoundly alters 
their function, indicating that the traffic 
flow on the bridge between the innate 
and adaptive immune response is 
indeed two-way.
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The Resident Retreat  
for Future Academicians
Donna A. Culton1, David S. Rubenstein1 and Luis A. Diaz1
The first Resident Retreat for Future Academicians was held in 2001 with the 
goal of recruiting and encouraging talented residents interested in careers in 
academia.  In this issue of the JID, Hill et al. present findings to suggest that the 
retreat has indeed fulfilled its goal.  It is our hope that the retreat, which is now 
in its tenth year, will continue to enlist the future leaders of our specialty.  
Journal of Investigative Dermatology (2010) 130, 1775–1777. doi:10.1038/jid.2010.133
1Department of Dermatology, University of North Carolina–Chapel Hill, Chapel Hill, North Carolina, USA
Correspondence: Luis A. Diaz, Department of Dermatology, University of North Carolina–Chapel Hill, 
Suite 3100 Thurston-Bowles Building, CB 7287, Chapel Hill, North Carolina 27599, USA.  
E-mail: ldiaz@med.unc.edu
As incoming President of the Society 
of Investigative Dermatology (SID) in 
2000, I (LAD) recognized four prob-
lems facing our Society: a decrease in 
membership, a decrease in the num-
ber of manuscripts submitted by US 
authors to the Journal of Investigative 
Dermatology, a fading interest of 
clinicians in research issues, and 
a shrinking pool of young derma-
tologists interested in biomedical 
research. I decided to work on the last 
problem with the approval of the SID 
Board of Directors. With the support 
and advice of incoming SID President 
Jouni Uitto, SID Secretary Paul R. 
Bergstresser, Barbara A. Gilchrest, 
Alice P. Pentland, Richard L. Edelson, 
